Showing results (121-130 of 192) with videos related to
Sort By:
Pageof 20
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 12, 2012
[Analysis of the efficacy and survival of third-line treatment in advanced non-small cell lung cancer]Lan Shao, Zhengbo Song, Lin Hu, et al.Cellular and Molecular Life Sciences : CMLS|December 21, 2022
Bcl6 drives stem-like memory macrophages differentiation to foster tumor progressionWeiwei Zhang, Qin Han, Yina Ding, et al.BMC Medicine|May 9, 2022
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trialZhengbo Song, Guangyuan Lou, Yina Wang, et al.Open Medicine (Warsaw, Poland)|March 14, 2023
Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysisXiaodong Gu, Jinfei Si, Yelan Guan, et al.Journal of Cellular and Molecular Medicine|February 10, 2021
EXT1 methylation promotes proliferation and migration and predicts the clinical outcome of non-small cell lung carcinoma via WNT signalling pathwayWencui Kong, Ying Chen, Zhongquan Zhao, et al.Molecular Therapy. Methods & Clinical Development|September 30, 2020
Evaluating the Potential of T Cell Receptor Repertoires in Predicting the Prognosis of Resectable Non-Small Cell Lung CancersZhengbo Song, Xiangbin Chen, Yi Shi, et al.Journal of Extracellular Vesicles|December 18, 2020
Extracellular vesicles: Natural liver-accumulating drug delivery vehicles for the treatment of liver diseasesGensheng Zhang, Xiaofang Huang, Huiqing Xiu, et al.Clinical Lung Cancer|March 8, 2020
Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective StudyTianle Shen, Xingxiang Pu, Liping Wang, et al.Therapeutic Advances in Medical Oncology|May 30, 2024
Poor efficacy of immune checkpoint inhibitor treatment in advanced thymic carcinoma patients with liver metastasesYue Hao, Manyi Xu, Xiaohong Zeng, et al.Journal of Cancer Research and Clinical Oncology|March 17, 2023
Pretherapy investigations using highly robust visualized biomarkers from CT imaging by multiple machine-learning techniques toward its prognosis prediction for ALK-inhibitor therapy in NSCLC: a feasibility studyJingjing Sun, Feng Li, Jiantao Yang, et al.Pageof 20